Multiple Myeloma
Conference Coverage
Lenalidomide combination improves QOL in newly diagnosed MM
©ASCO/Scott Morgan CHICAGO—Substituting lenalidomide for thalidomide in the standard treatment of newly diagnosed multiple myeloma (MM) improves...
News
Method reveals new targets of p53
Credit: A.T.
News
Wealth appears to affect distribution of cancer types
Credit: Rhoda Baer Results of a large study suggest certain malignanices are more concentrated in areas with high levels of poverty, while other...
News
mAb gets breakthrough designation for MM
Credit: Linda Bartlett The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for elotuzumab, a humanized...
News
Cancer trial publications often omit minority accrual rates
Credit: Rhoda Baer A review of clinical trial data from 2012 suggests Hispanic patients are underrepresented in US cancer studies, and many trial...
News
Chip may allow for early cancer detection
Institute of Photonic Sciences Scientists say they’ve developed a lab-on-a-chip device capable of detecting protein markers for cancer. The...
News
How cancer-fighting protein is held in check
Credit: A.T.
News
Virotherapy shows activity against MM
Credit: CDC Results of a proof-of-principle study suggest virotherapy can be effective against multiple myeloma (MM). The study included 2 MM...
News
Protein inhibition confers radioprotective effects
Researchers believe they may have discovered a method for treating and preventing radiation-induced gastrointestinal toxicity. The investigators...
News
Team says antioxidant has no effect on cancer risk, overall health
Contrary to previous findings, a new study suggests the antioxidant resveratrol is not associated with improvements in health, including reducing...
News
Group finds CAR T-cell therapy can fight MM
showing multiple myeloma Results of preclinical research indicate chimeric antigen receptor (CAR) T cells are effective against multiple myeloma...